Adj A/Prof Loh is currently a Senior Consultant and Clinical Lead of Acute Myocardial Infarction Service, Department of Cardiology, at the National University Heart Centre, Singapore (NUHCS).
He graduated from the University College Dublin, Ireland in 1998 and received his medical and cardiology specialist training in the United Kingdom. Adj A/Prof Loh’s cardiology training also included research in the field of heart failure and refractory angina; and interventional fellowship at the Rigshospitalet University Heart Centre in Copenhagen, Denmark. Adj A/Prof Loh has obtained Fellowship of the Royal College of the Physicians (FRCP) and is currently the lead for Western STEMI Network and acute coronary syndrome program in the NUHCS.
Awards
2018 - NUHS Mochtar Riady Pinnacle Awards (Team)
Journals & Publications
Asia Pacific Consensus Document on Coronary Bifurcation Interventions. PH Loh; JF Lassen, N Jepson, B-K Koo, SL Chen, SA Harding, FH Hu, S Lo, WA Wan Ahmad, F Ye, G Guagliumi, MS Hiremath, S Uemura, LF Wang, A Whelan, A Low. Eurointervention 2020 Apr [Online ahead of print – doi:10.4244/EIJ-D-19-00977]
The Global Impact of the COVID-19 Pandemic on STEMI care: A Systematic Review and Meta-analysis. NWS Chew, ZGW Ow, VXT Teo, RRY Heng, CH Ng, AF Low, MYY Chan, TC Yeo, HC Tan, PH Loh. Canadian Journal of Cardiology. Available online Arpil 2021 DOI: https://doi.org/10.1016/j.cjca.2021.04.003
Characteristics and outcomes of young patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: retrospective analysis in a multiethnic Asian population. BWL Tung, ZZ Ng, W Kristanto, KW Saw, S-P Chan, W Sia, KH Chan, M Chan, W kong, R Lee, JPY Loh, AF Low, KK Poh, E Tay, HC Tan, TC Yeo, PH Loh. Open Heart 2021:8(1):e001437
ST-segment elevation myocardial infarction hospitalizations remain unchanged during COVID-19. CY Koo, S-P Chan, BWL Tung, HC Tan, PH Loh. Singapore Med J 2020. Online ahead of print doi: 10.11622/smedj.2020157
Impact of the COVID-19 Pandemic on Door-to-balloon Time for Primary Percutaneous Coronary Intervention. N Chew, C-H Sia, HL Wee, BJD Loh, S Rastogi, P Kojodjojo, DWP Chor, BSH Leong, BCP Koh, H Tam, LS Quek, W Sia, KW Saw, BWL Tung, ZZY Ng, A Ambhore, E LW Tay, KH Chan, CH Lee, JPY Loh, AFH Low, M Chan, TC Yeo, HC Tan, PH Loh. Circulation J 2021;85(2):139-149
Clinical outcomes one year and beyond after combination sirolimus eluting endothelial progenitor cell capture stenting during primary percutaneous coronary intervention in ST-sgement elevation myocardial infarction. HW Sim, E H Thong, HC Tan, AF Low, C-H Lee, MY Chan, EL Tay, PH Loh, KH Chan, JP Loh. Cardiovascular Revascularization Medicine 2019;20(9):739-743
Treatment of very small de novo Coronary Artery Disease with 2.0 mm Drug-coated balloons showed 1-year Clinical Outcome Comparable with 2.0 mm Drug-eluting Stents. HW Sim, R Ananthakrishna, SP Chan, AF Low, R CH Lee, M Chan, E Tay, PH Loh, KH Loh, HC Tan, JPY Loh. The Journal of Invasive Cardiology 2018;30(7):256-261
Incidence and predictors of target lesion failure in multiethnic Asian population receiving the SYNERGY coronary stent: A prospective all-comers registry. R Ananthakrishna, W Kristanto, L Liu, SP , Chan, PH Loh, EL Tay, KH Chan, MY Chan, CH Lee, AF Low, HC Tan, JP Loh. Catheter Cardiovasc Interv. 2018;92(6):1097-1103
The COMBO dual therapy stent in patients presenting with acute ST-elevation myocardial infarction: a one-year follow-up study. R Ananthakrishna, W Kristanto, L Liu, PH Loh, E Tay, KH Chan, M Chan, C-H Lee, A Low, HC Tan, J Loh. AsiaIntervention 2017;3:21-27
The effectiveness of Enhanced External Counterpulsation (EECP) in patients suffering from chronic refractory angina previously treated with Transmyocardial Laser Revascularisation. PH Loh, E Kennard, CV Bourantas, R Chelliah, P Atkin, J Cook, JG Cleland, A Michaels, JCK Hui. J International Cardiology 2013;168(4):4383-4385 [Epub 25 May 2013]